Yes, both Retatrutide and Tirzepatide can be used by individuals without diabetes
[DOI] [PubMed] [Google Scholar] 13.Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP
Its 2022 disclosure by Coskun and colleagues (Cell Metabolism) marked a deliberate extension of the dual-incretin agonist concept pioneered by tirzepatide, adding glucagon receptor engagement to the pharmacological palette
D., & Sadovsky, R
GHKCu restores oxidative stressinduced damage via antioxidant enzyme activation in vitro. Cosmetics
Purpose: we present a model of chronic infarction in rabbits for the analysis of inducibility of ventricular fibrillation (VF) and/or sustained ventricular tachycardia (VT), as a previous step to further investigations to elucidate the arrhythmogenic role of fibrosis